Differential fetal and maternal contributions to the cytokine milieu in a murine model of infection-induced preterm birth

被引:53
作者
Hirsch, E [1 ]
Blanchard, R [1 ]
Mehta, SP [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA
关键词
cytokines; infection; mouse; pregnancy;
D O I
10.1016/S0002-9378(99)70227-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The aim of the study was to determine the relative productions by maternal and fetal tissues of proinflammatory and anti-inflammatory cytokines in a murine model of infection-induced preterm delivery. STUDY DESIGN: The right uterine horns of CD-1 female mice at 14.5 days of a 19- to eo-day gestation were inoculated with either sterile media or live Escherichia coli. The concentrations of cytokines within uteri, placentas, membranes, and fetal lower body segments were determined by enzyme-linked immunosorbent assay at various times after inoculation. RESULTS: All infected tissues showed large, time-dependent increases in interleukin 1 alpha, interleukin 1 beta, and interleukin 6. These increases were maximal 13 hours after infection and were highest in uteri (15-60 times levels in uninfected tissues). Increases in tumor necrosis factor a and interleukin 1 receptor antagonist were much smaller (3 to 5 times) and were confined to the uterus. Although the uterus contained the greatest concentrations of interleukin 1 alpha, interleukin 1 beta, interleukin 6, and tumor necrosis factor alpha, fetal bodies and placentas contained the highest levels of interleukin 1 receptor antagonist. CONCLUSIONS: Time-dependent increases in maternal and fetal cytokines occurred after acute bacterial infection in this murine model. The fetus and placenta may be the most significant sources of the anti-inflammatory cytokine interleukin 1 receptor antagonist during pregnancy, whereas the uterus appears to be a more important source of interleukin 1, interleukin 6, and tumor necrosis factor alpha. Interleukin 1 receptor antagonist levels within uteri were insufficiently high to effectively inhibit interleukin 1 activity during infection.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 19 条
[1]   INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :167-227
[2]   TRANSFORMING GROWTH-FACTOR-BETA-2 PREVENTS PRETERM DELIVERY INDUCED BY INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN THE RABBIT [J].
BRY, K ;
HALLMAN, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (04) :1318-1322
[3]   TRANSFORMING GROWTH-FACTOR-BETA OPPOSES THE STIMULATORY EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR ON AMNION CELL PROSTAGLANDIN-E2 PRODUCTION - IMPLICATION FOR PRETERM LABOR [J].
BRY, K ;
HALLMAN, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (01) :222-226
[4]   INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE FETOMATERNAL COMPARTMENT [J].
BRY, K ;
TERAMO, K ;
LAPPALAINEN, U ;
WAFFARN, F ;
HALLMAN, M .
ACTA PAEDIATRICA, 1995, 84 (03) :233-236
[5]   THE VALUE OF AMNIOTIC-FLUID INTERLEUKIN-6 DETERMINATION IN PATIENTS WITH PRETERM LABOR AND INTACT MEMBRANES IN THE DETECTION OF MICROBIAL INVASION OF THE AMNIOTIC CAVITY [J].
COULTRIP, LL ;
LIEN, JM ;
GOMEZ, R ;
KAPERNICK, P ;
KHOURY, A ;
GROSSMAN, JH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (04) :901-911
[6]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346
[7]  
HILLIER SL, 1993, OBSTET GYNECOL, V81, P941
[8]   A MODEL OF INTRAUTERINE INFECTION AND PRETERM DELIVERY IN MICE [J].
HIRSCH, E ;
SAOTOME, I ;
HIRSH, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (05) :1598-1603
[9]   EXPRESSION OF INFLAMMATORY CYTOKINES (INTERLEUKIN-1-BETA AND INTERLEUKIN-6) IN AMNIOCHORIONIC MEMBRANES [J].
MENON, R ;
SWAN, KF ;
LYDEN, TW ;
ROTE, NS ;
FORTUNATO, SJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (02) :493-500
[10]   INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR STIMULATE ARACHIDONIC-ACID RELEASE AND PHOSPHOLIPID-METABOLISM IN HUMAN MYOMETRIAL CELLS [J].
MOLNAR, M ;
ROMERO, R ;
HERTELENDY, F .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (04) :825-829